129 related articles for article (PubMed ID: 23235347)
1. α-Methylacyl-CoA racemase (AMACR) in gastric cancer: correlation with clinicopathologic data and disease-free survival.
Mroz A; Kiedrowski M; Lewandowski Z
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):313-7. PubMed ID: 23235347
[TBL] [Abstract][Full Text] [Related]
2. Alpha-methylacyl-CoA-racemase expression in adenocarcinoma, dysplasia and non-neoplastic epithelium of the stomach.
Lee WA
Oncology; 2006; 71(3-4):246-50. PubMed ID: 17652945
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
4. AMACR is highly expressed in gastric adenomas and intestinal-type carcinomas.
Cho EY; Kim KM; Park CK; Kim JJ; Sohn TS; Kim DW
APMIS; 2007 Jun; 115(6):713-8. PubMed ID: 17550379
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of the expression of alpha-methylacyl-CoA racemase in squamous cell carcinoma and adenocarcinoma of the lung.
Erdogan Y; Demirag F; Duyar SS; Yilmaz A; Yazici U; Aydoğdu K
Acta Chir Belg; 2013; 113(4):263-9. PubMed ID: 24224435
[TBL] [Abstract][Full Text] [Related]
6. A study of indefinite for dysplasia in Barrett's oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (alpha-methylacyl-CoA-racemase).
Sonwalkar SA; Rotimi O; Scott N; Verghese E; Dixon M; Axon AT; Everett SM
Histopathology; 2010 Jun; 56(7):900-7. PubMed ID: 20636793
[TBL] [Abstract][Full Text] [Related]
7. Alpha-methylacyl-CoA racemase/P504S overexpression in colorectal carcinoma is correlated with tumor differentiation.
Shi X; Gong E; Wu X
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):175-80. PubMed ID: 17525630
[TBL] [Abstract][Full Text] [Related]
8. Value of α-methylacyl-CoA racemase immunochemistry for predicting neoplastic progression in Barrett's oesophagus.
Kastelein F; Biermann K; Steyerberg EW; Verheij J; Kalisvaart M; Looijenga LH; Stoop HA; Walter L; Kuipers EJ; Spaander MC; Bruno MJ;
Histopathology; 2013 Nov; 63(5):630-9. PubMed ID: 24004067
[TBL] [Abstract][Full Text] [Related]
9. a-Methylacyl coenzyme A racemase is highly expressed in the intestinal-type adenocarcinoma and high-grade dysplasia lesions of the stomach.
Huang W; Zhao J; Li L; Huang Y; Yang X; Wang J; Zhang T
Histol Histopathol; 2008 Nov; 23(11):1315-20. PubMed ID: 18785113
[TBL] [Abstract][Full Text] [Related]
10. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
[TBL] [Abstract][Full Text] [Related]
11. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.
Ananthanarayanan V; Deaton RJ; Yang XJ; Pins MR; Gann PH
Prostate; 2005 Jun; 63(4):341-6. PubMed ID: 15602744
[TBL] [Abstract][Full Text] [Related]
12. Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicator.
Wu LC; Chen LT; Tsai YJ; Lin CM; Lin CY; Tian YF; Sheu MJ; Uen YH; Shiue YL; Wang YH; Yang SJ; Wu WR; Li SH; Iwamuro M; Kobayasshi N; Huang HY; Li CF
J Clin Pathol; 2012 Apr; 65(4):309-14. PubMed ID: 22267983
[TBL] [Abstract][Full Text] [Related]
13. Alpha-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: expression and survival analysis.
Shilo K; Dracheva T; Mani H; Fukuoka J; Sesterhenn IA; Chu WS; Shih JH; Jen J; Travis WD; Franks TJ
Arch Pathol Lab Med; 2007 Oct; 131(10):1555-60. PubMed ID: 17922592
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of α-methylacyl-CoA racemase is associated with CTNNB1 mutations in hepatocellular carcinomas.
Sekine S; Ogawa R; Ojima H; Kanai Y
Histopathology; 2011 Apr; 58(5):712-9. PubMed ID: 21457159
[TBL] [Abstract][Full Text] [Related]
15. The expression and clinical effects of alpha-methylacyl-CoA racemase (AMACR/ P504S) as an immunohistochemical marker in malign pleural mesothelioma.
Duyar SŞ; Yilmaz A; Demirag F; Erdoğan Y; Yazici Ü; Karakaya J
Turk J Med Sci; 2015; 45(3):607-14. PubMed ID: 26281327
[TBL] [Abstract][Full Text] [Related]
16. Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression.
Langner C; Rupar G; Leibl S; Hutterer G; Chromecki T; Hoefler G; Rehak P; Zigeuner R
Virchows Arch; 2006 Mar; 448(3):325-30. PubMed ID: 16315020
[TBL] [Abstract][Full Text] [Related]
17. Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases.
Jiang Z; Fanger GR; Woda BA; Banner BF; Algate P; Dresser K; Xu J; Chu PG
Hum Pathol; 2003 Aug; 34(8):792-6. PubMed ID: 14506641
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human α-methylacyl CoA racemase (AMACR): a target for prostate cancer.
Carnell AJ; Kirk R; Smith M; McKenna S; Lian LY; Gibson R
ChemMedChem; 2013 Oct; 8(10):1643-7. PubMed ID: 23929631
[TBL] [Abstract][Full Text] [Related]
19. AMACR overexpression acts as a negative prognostic factor in oral squamous cell carcinoma.
He HL; Lee YE; Chang MT; Shiue YL; Chang SL; Chen TJ; Chiu CT
Int J Med Sci; 2018; 15(6):638-644. PubMed ID: 29725255
[No Abstract] [Full Text] [Related]
20. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker.
Jiang Z; Wu CL; Woda BA; Iczkowski KA; Chu PG; Tretiakova MS; Young RH; Weiss LM; Blute RD; Brendler CB; Krausz T; Xu JC; Rock KL; Amin MB; Yang XJ
Histopathology; 2004 Sep; 45(3):218-25. PubMed ID: 15330799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
